Report : Middle East and Africa Nasal Delivery Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care Settings, Hospitals, and Clinics); and Country
Home Care Settings Segment Held Largest Share of End User in Middle East and Africa Nasal Delivery Devices Market in 2019
According to a new market research study of ‘Middle East and Africa Nasal Delivery Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by drug type, delivery technologies, and end user’ the Middle East and Africa nasal delivery devices market is expected to reach US$ 5,711.89 million in 2027 from US$ 4,094.32 in 2019. The market is estimated to grow with a CAGR of 4.3% from 2020-2027. The report provides trends prevailing in the Middle East and Africa nasal delivery devices market and the factors driving market along with those that act as hindrances.
Based on the end user, the Middle East and Africa the nasal delivery devices market, is segmented into home care settings, hospitals, and clinics. The home care settings segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. Home care setting is a system of care provided by skilled practitioners to patients in their homes under the direction of a physician. Home health care services include nursing care, physical, occupational, and speech-language therapy; and medical social services. One of the most complicated patient requirements is the use of a nasal delivery devices in order to maintain breathing. The nasal route is easily accessible for self-administration without the help of health professionals, and no needle stick hazards are associated with nasal administration in in homecare setting.
The growth of the market is attributed to some key driving factors such as the increasing government initiatives and the rising public awareness and the rising prevalence of non-communicable diseases and respiratory disorders. However, the market growth is likely to be hindered owing to the limitations regarding nasal delivery medications.
Sanofi, GlaxoSmithKline plc., AstraZeneca are among the leading companies operating in the Middle East and Africa nasal delivery devices market.
The report segments Middle East and Africa Nasal Delivery Devices Market as Follows:
By Drug Type
- Pain Relief Drugs
- Calcium Supplements
By Delivery Technologies
By End User
- Home Care Settings
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Contact Person: Sameer Joshi
Email Id: email@example.com